• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Devices

Thoratec Corp

+ Add to Watchlist


32.6400 USD 0.0300 0.09%

As of 20:10:00 ET on 12/19/2014.

Snapshot for Thoratec Corp (THOR)

Open: 32.5400 Day's Range: 32.4850 - 33.1001 Volume: 1,261,481
Previous Close: 32.6100 52wk Range: 22.5000 - 38.6900 1-Yr Rtn: -9.18%

Stock Chart for THOR

No chart data available.
  • THOR:US 32.6400
  • 1D
  • 1M
  • 1Y
Interactive THOR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for THOR

Current P/E Ratio (ttm) 33.1004
Estimated P/E(12/2014) 25.9873
Relative P/E vs. SPX 1.8066
Earnings Per Share (USD) (ttm) 0.9861
Est. EPS (USD) (12/2014) 1.2560
Est. PEG Ratio 4.5274
Market Cap (M USD) 1,795.20
Shares Outstanding (M) 55.00
30 Day Average Volume 825,921
Price/Book (mrq) 2.7587
Price/Sale (ttm) 3.8669
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/04/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for THOR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for THOR

Thoratec Corporation researches, develops, manufactures, and markets medical devices for circulatory support and vascular graft applications. The Company's products include a ventricular assist device, an implantable left ventricular heart assist device, a vascular access graft, and a coronary artery bypass graft. Thoratec also supplies whole-blood coagulation testing equipment.

D Keith GrossmanPresident/CEONiamh PellegriniPres:North America
David A LehmanSenior VP/Secy/Gen CnslVasant PadmanabhanSenior VP:Technical Ops
More Company Profile & Key Executives for THOR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil